Skip to content

Negative Predictive Value of Drug Provocation Tests to Beta-lactams

Negative Predictive Value of Drug Provocation Tests to Beta-lactams

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02844712
Acronym
NPVDPT
Enrollment
750
Registered
2016-07-26
Start date
2014-12-31
Completion date
2016-11-30
Last updated
2016-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Hypersensitivity

Keywords

Drug hypersensitivity, Betalactam, Drug provocation test

Brief summary

Patients with a complete drug allergy work-up to betalactam antibiotics were contacted (by mail) and asked to answer a questionnaire regarding the tolerance upon readministration of a negatively tested beta-lactam.

Interventions

OTHEREvaluation of reexposure to a negatively tested betalactam

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elderly patients with at least 5 years at the time of consultation for allergy suspected allergy to beta-lactam antibiotics in the University Hospital of Montpellier and with a negative provocation test to a betalactam * The patient or the patient's legal representatives are not their opposition to participate in this study * The patient must be affiliated or beneficiary in a health insurance system

Exclusion criteria

* The patient is exclusion period determined by a previous study * The patient is under judicial protection, guardianship or curatorship * The patient or the patient's legal representatives do not read fluently the French language

Design outcomes

Primary

MeasureTime frame
Negative predictive value of drug provocation tests to betalactamsone day

Secondary

MeasureTime frame
The types of reactions upon reexposure to a negatively tested betalactamone day

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026